Vascular Closure Devices Market | Key players in the Vascular Closure Devices Market include Terumo Corporation (Japan), Abbott (U.S.), Cardinal Health Inc. (U.S.), Cardiva Medical Inc. (U.S.), and Morris Innovative, Inc. (U.S.).

The report "Vascular Closure Device Market by Type (Passive Approximators (Collagen Plugs Sealent/Gel Based), Active Approximators (Clip, Suture Devices)), Access (Femoral,Radial) & Procedure (Interventional Cardiology, Radiology) - Global Forecasts to 2022", report provides a detailed overview of the major drivers, restraints, opportunities, and threats impacting the vascular closure devices market along with the estimates and forecasts of the revenue and market share analysis.

Browse 61 market data tables and 30 figures spread through 128 pages and in-depth TOC on "Vascular Closure Device Market by Type (Passive Approximators (Collagen Plugs Sealent/Gel Based), Active Approximators (Clip, Suture Devices)), Access (Femoral,Radial) & Procedure (Interventional Cardiology, Radiology) - Global Forecasts to 2022"

http://www.marketsandmarkets.com/Market-Reports/vascular-closure-device-market-180101468.html?utm_source=OpenPR&utm_medium=Paid

Early buyers will receive 10% customization on reports.

The global vascular closure devices market is expected to reach USD 984.6 Million by 2022 from USD 704.8 Million in 2017, at a CAGR of 6.9%. Growth in this market can be attributed to factors such as the large number of approvals for vascular closure devices, high prevalence of cardiovascular diseases and obesity, and increasing focus of market players on large-bore vascular closure devices.

The market is segmented on the basis of type, access type, procedure type, and regions. Based on type, the market segment is further categorized into active approximators, passive approximators, and external hemostasis devices. Passive approximators are expected to account for the largest share of the market in 2017. Collagen-based passive approximators are widely used owing to the wide range of advantages associated with these devices, including ease of use, short ambulation time for patients, and fewer complications compared to manual compression.

Download PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=180101468&utm_source=OpenPR&utm_medium=Paid

Based on access, the market is broadly classified into femoral access and radial access. The femoral access segment is estimated to account for the largest share of the market in 2017. With an increasing number of cardiologists and physicians opting for femoral access in interventional procedures, the market is expected to witness significant growth in the coming years.

On the basis of procedures, the market is segmented into interventional cardiology and interventional radiology/vascular surgery. The interventional cardiology segment is expected to dominate this market in 2017. The large share of this segment can be attributed to the high prevalence of cardiovascular diseases and the rapidly increasing obese population.

On the basis of geography, the market is segmented into North America, Europe, Asia-Pacific, and RoW (Rest of the World). Of these, the North American segment is expected to account the largest share of the market in 2017. Market growth is primarily driven by factors such as the high prevalence of cardiovascular diseases, increasing number of research studies and clinical trials for vascular closure devices in the U.S., and the growing trend of one-day surgery for vascular procedures, Moreover, the increasing number of cardiac arrest cases, long waiting periods for cardiac surgery likely to encourage the adoption of minimally invasive procedures in Canada, are other factors driving the growth of this market in this region.

Speak to Analyst @ http://www.marketsandmarkets.com/speaktoanalyst.asp?id=180101468&utm_source=OpenPR&utm_medium=Paid

Some prominent players in the market include Terumo Corporation (Japan), Abbott (U.S.), Cardinal Health Inc. (U.S.), Cardiva Medical Inc. (U.S.), and Morris Innovative, Inc. (U.S.).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com

This release was published on openPR.